FIELD: organic chemistry, heterocyclic compounds, pharmacy. SUBSTANCE: invention relates to novel guanidyl heterocyclic compounds of the formula (I) where R1 means H, alkyl or absent; when R1 absent then bond (a) is a double one, D means CR2 where R2 is taken among H, alkyl, halogen atom, or when B means CR3 then D can mean N; B means NR9, CR3=CR8, CR3, S where R9 means H, alkyl, alkenyl or alkynyl and where R3 and R8 are taken among H, alkyl, alkenyl, alkynyl or cyano-group; each of R4, R5, R6 is taken independently among H, alkyl, alkenyl, alkynyl, cyano-group or NH=C(=NR10)NHR11 (guanidinyl); R10 and R11 are taken among H, methyl and ethyl and where only one of R1, R5 and R6 means guanidinyl; R7 is taken among H, alkyl, alkenyl, alkynyl and halogen atom. These compounds show agonistic activity with respect to alpha-2 adrenoceptors and therefore in common with pharmaceutically acceptable carrier can form pharmaceutical composition. Invention relates also to method of activation of alpha-2 adrenoceptors for prophylaxis and treatment of diseases when agonists of alpha-2 adrenoceptors are effective agents for diseases relief. EFFECT: valuable medicinal properties of compounds. 7 cl
Authors
Dates
2002-12-20—Published
1997-11-21—Filed